Israel Englander Voyager Therapeutics, Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 100,725 shares of VYGR stock, worth $846,090. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100,725

Holding current value

$846,090

% of portfolio

0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.15 - $10.84 $720,183 - $1.09 Million	100,725 New	100,725 $937,000
Q2 2023 Aug 14, 2023	SELL	$6.94 - $13.99 $7.96 Million - $16.1 Million	-1,147,333 Reduced 98.69%	15,220 $174,000
Q1 2023 May 15, 2023	BUY	$6.0 - $10.78 $5.3 Million - $9.53 Million	883,899 Added 317.2%	1,162,553 $8.96 Million
Q4 2022 Feb 14, 2023	SELL	$4.94 - $6.61 $218,451 - $292,300	-44,221 Reduced 13.7%	278,654 $1.7 Million
Q3 2022 Nov 14, 2022	SELL	$5.57 - $7.47 $2.82 Million - $3.78 Million	-505,921 Reduced 61.04%	322,875 $1.91 Million

Q2 2022 Aug 15, 2022	BUY	$4.82 - $10.09 $3.12 Million - $6.53 Million	646,814 Added 355.43%	828,796 $4.9 Million
Q1 2022 May 16, 2022	SELL	$2.75 - $9.44 $662,959 - $2.28 Million	-241,076 Reduced 56.98%	181,982 $1.39 Million
Q4 2021 Feb 14, 2022	BUY	$2.47 - $5.55 $369,754 - $830,823	149,698 Added 54.76%	423,058 $1.15 Million
Q3 2021 Nov 15, 2021	SELL	$2.63 - $4.12 $643,040 - $1.01 Million	-244,502 Reduced 47.21%	273,360 $719,000
Q2 2021 Aug 16, 2021	BUY	$3.94 - $5.44 $2.04 Million - $2.82 Million	517,862 New	517,862 $2.14 Million
Q2 2020 Aug 14, 2020	SELL	$8.05 - $14.21 $1.79 Million - $3.16 Million	-222,298 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$6.8 - $14.66 $1.84 Million - $3.96 Million	-270,365 Reduced 54.88%	222,298 $2.03 Million
Q4 2019 Feb 14, 2020	BUY	$12.82 - $16.85 $6.32 Million - $8.3 Million	492,663 New	492,663 $6.87 Million
Q3 2019 Nov 14, 2019	SELL	$16.31 - $28.29 $7.96 Million - $13.8 Million	-488,281 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$19.18 - $27.88 $6.58 Million - $9.57 Million	343,213 Added 236.59%	488,281 $13.3 Million
Q1 2019 May 14, 2019	SELL	$8.0 - $19.66 $2.11 Million - $5.19 Million	-264,202 Reduced 64.55%	145,068 $2.78 Million
Q4 2018 Feb 14, 2019	SELL	$8.59 - $18.05 $501,192 - $1.05 Million	-58,346 Reduced 12.48%	409,270 $3.85 Million
Q3 2018 Nov 14, 2018	SELL	$17.11 - $21.74 $2.61 Million - $3.31 Million	-152,302 Reduced 24.57%	467,616 $8.85 Million
Q2 2018 Aug 14, 2018	BUY	$16.76 - $23.92 $31,793 - $45,376	1,897 Added 0.31%	619,918 $12.1 Million
Q1 2018 May 15, 2018	BUY	$16.16 - $31.31 $5.53 Million - $10.7 Million	342,148 Added 124.02%	618,021 $11.6 Million
Q4 2017 Feb 14, 2018	BUY	$12.26 - $25.88 $3.38 Million - $7.14 Million	275,873	275,873 $4.58 Million

Others Institutions Holding VYGR

# of Institutions

134

Shares Held

34.2M

Call Options Held

35.3K

Put Options Held

63K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $325M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account